1. Home
  2. ABCL vs WINA Comparison

ABCL vs WINA Comparison

Compare ABCL & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$9.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Winmark Corporation

WINA

Winmark Corporation

HOLD

Current Price

$371.26

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
WINA
Founded
2012
1988
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
ABCL
WINA
Price
$9.44
$371.26
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.40
N/A
AVG Volume (30 Days)
6.1M
37.8K
Earning Date
05-11-2026
04-15-2026
Dividend Yield
N/A
3.76%
EPS Growth
10.91
3.76
EPS
N/A
5.31
Revenue
$75,128,000.00
$86,055,700.00
Revenue This Year
N/A
$5.55
Revenue Next Year
$21.85
$6.03
P/E Ratio
N/A
$70.82
Revenue Growth
160.56
5.86
52 Week Low
$2.75
$325.06
52 Week High
$10.01
$526.81

Technical Indicators

Market Signals
Indicator
ABCL
WINA
Relative Strength Index (RSI) 77.04 53.24
Support Level $3.38 $362.23
Resistance Level N/A $397.91
Average True Range (ATR) 0.51 12.21
MACD 0.29 4.04
Stochastic Oscillator 87.97 97.87

Price Performance

Historical Comparison
ABCL
WINA

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: